Seyed Moayed Alavian

2002–2023 年に発表

62
論文数
28,472
被引用数
47
h 指数
61
i10 指数

被引用数

Seyed Moayed Alavian の年別被引用数1985 年: 被引用 1 件2000 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 5 件2005 年: 被引用 4 件2006 年: 被引用 10 件2007 年: 被引用 8 件2008 年: 被引用 18 件2009 年: 被引用 7 件2010 年: 被引用 15 件2011 年: 被引用 13 件2012 年: 被引用 14 件2013 年: 被引用 14 件2014 年: 被引用 26 件2015 年: 被引用 34 件2016 年: 被引用 42 件2017 年: 被引用 53 件2018 年: 被引用 131 件2019 年: 被引用 941 件2020 年: 被引用 1,879 件2021 年: 被引用 2,088 件2022 年: 被引用 1,540 件2023 年: 被引用 958 件2024 年: 被引用 1,481 件2025 年: 被引用 521 件2026 年: 被引用 20 件1986〜1999 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,579 件、この内訳の 13.4%中国: 引用元論文 2,572 件、この内訳の 13.3%イギリス: 引用元論文 1,461 件、この内訳の 7.6%オーストラリア: 引用元論文 919 件、この内訳の 4.8%カナダ: 引用元論文 692 件、この内訳の 3.6%ドイツ: 引用元論文 690 件、この内訳の 3.6%イタリア: 引用元論文 596 件、この内訳の 3.1%スペイン: 引用元論文 479 件、この内訳の 2.5%イラン: 引用元論文 442 件、この内訳の 2.3%オランダ: 引用元論文 442 件、この内訳の 2.3%インド: 引用元論文 422 件、この内訳の 2.2%スイス: 引用元論文 378 件、この内訳の 1.9%
0%13.4%その他 39.4%

分野

  • Medicine59.2%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Neuroscience5.5%
  • Psychology5.3%
  • Environmental Science3.9%
  • Health Professions3.4%
  • その他14.9%

トピック

  • Liver Disease Diagnosis and Treatment2.1%
  • Musculoskeletal pain and rehabilitation2%
  • Nutritional Studies and Diet1.3%
  • Hepatitis C virus research1.2%
  • Tryptophan and brain disorders1.2%
  • Hepatitis B Virus Studies1.1%
  • その他91.1%

共著者

全論文

検索で開く
  1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Rakesh Aggarwal, Sargis A. Aghayan, Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Nadia Akseer, Ziyad Al‐Aly, Ayman Al‐Eyadhy, Hesham M. Al‐Mekhlafi, Rajaa Al‐Raddadi, Fares Alahdab, Khurshid Alam, Shazia Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh‐Navaei, Syed Mohamed Aljunid, Ala’a Alkerwi, François Alla, Peter Allebeck, Mohamed M L Alouani, Khalid A Altirkawi, Nelson Alvis‐Guzmán, Azmeraw T. Amare, Léopold Ndemnge Aminde, Walid Ammar, Yaw Ampem Amoako, Nahla Anber, Cătălina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Carl Abelardo T. Antonio, Palwasha Anwari, Jalal Arabloo, Antonio Araúz, Olatunde Aremu, Filippo Ariani, Bahroom Armoon, Johan Ärnlöv, Amit Arora, Al Artaman, Krishna K Aryal, Hamid Asayesh, Rana Jawad Asghar, Zerihun Ataro, Sachin Atre, Marcel Ausloos, Leticia Ávila‐Burgos, Euripide Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Peter Azzopardi, Arefeh Babazadeh, Hamid Badali, Alaa Badawi, Ayele Geleto ほか 890 名 - The Lancet 2018 被引用: 14,041

  2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zanfina Ademi, Olatunji Adetokunboh, Mina G Adib, Amha Admasie, José Carmelo Adsuar, Kossivi Agbélénko Afanvi, Mohsen Afarideh, Gina Agarwal, Anju Aggarwal, Sargis A. Aghayan, Anurag Agrawal, Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Mohammad Esmaeil Akbari, Tomi Akinyemiju, Nadia Akseer, Ziyad Al‐Aly, Ayman Al‐Eyadhy, Hesham M. Al‐Mekhlafi, Fares Alahdab, Khurshid Alam, Samiah Alam, Shazia Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Komal Ali, Syed Mustafa Ali, Mehran Alijanzadeh, Reza Alizadeh‐Navaei, Syed Mohamed Aljunid, Ala’a Alkerwi, François Alla, Ubai Alsharif, Khalid A Altirkawi, Nelson Alvis‐Guzmán, Azmeraw T. Amare, Walid Ammar, Nahla Anber, Jason A Anderson, Cătălina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Josep M. Antó, Carl Abelardo T. Antonio, Palwasha Anwari, Lambert Appiah, Seth Christopher Yaw Appiah, Jalal Arabloo, Olatunde Aremu, Johan Ärnlöv, Al Artaman, Krishna Kumar Aryal, Hamid Asayesh, Zerihun Ataro, Marcel Ausloos, Euripide Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Ayuk Betrand Tambe, Peter Azzopardi ほか 943 名 - The Lancet 2018 被引用: 5,028

  3. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kossivi Agbelenko Afanvi, Mohsen Afarideh, Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Rakesh Aggarwal, Sargis Aghasi Aghayan, Anurag Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Sayem Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Nadia Akseer, Ziyad Al-Aly, Ayman Al-Eyadhy, Hesham M Al-Mekhlafi, Rajaa M Al-Raddadi, Fares Alahdab, Khurshid Alam, Tahiya Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh-Navaei, Syed Mohamed Aljunid, Ala'a Alkerwi, François Alla, Peter Allebeck, Jordi Alonso, Ubai Alsharif, Khalid Altirkawi, Nelson Alvis-Guzman, Leopold N Aminde, Erfan Amini, Mohammadreza Amiresmaili, Walid Ammar, Yaw Ampem Amoako, Nahla Hamed Anber, Catalina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Carl Abelardo T Antonio, Palwasha Anwari, Jalal Arabloo, Olatunde Aremu, Johan Ärnlöv, Amit Arora, Megha Arora, Al Artaman, Krishna K Aryal, Hamid Asayesh, Zerihun Ataro, Marcel Ausloos, Leticia Avila-Burgos, Euripide F G A Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Peter S Azzopardi, Arefeh Babazadeh, Hamid Badali, Kalpana Balakrishnan ほか 880 名 - The Lancet 2018 被引用: 4,191

  4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amarsanaa Jazag, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben‐Ari, Aïcha Bensalem, Fernando Bessone, Mia Biondi, Abdul Rahman Bizri, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Carol Brosgart, Kimberly Brown, Robert Brown, Jr, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Joaquin Cabezas, Teresa Casanovas, Chungman Chae, Henry Lik Yuen Chan, Hugo Cheinquer, Pei-Jer Chen, Kent Jason Cheng, Myeong-Eun Cheon, Cheng-Hung Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan-Long Chuang, Vladimir Chulanov, Laura Cisneros, Carla Coffin, Fernando Contreras, Nicola Coppola, Markus Cornberg, Benjamin Cowie, Matthew Cramp, Antonio Craxi, Javier Crespo, Fuqiang Cui, Chris Cunningham, Olav Dalgard, Robert De Knegt, Victor De Ledinghen, Gregory Dore, Sylvia Drazilova, Ann-Sofi Duberg, Steve Egeonu, Mohammed Elbadri, Mohamed El-Kassas, Manal El-Sayed, Chris Estes, Ohad Etzion, Elmobashar Farag, Laurent Ferradini, Paulo Ferreira, Robert Flisiak, Xavier Forns, Sona Frankova, James Fung, Edward Gane, Virginia Garcia, Javier García-Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe ほか 169 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 404

  5. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

    著者: , , , , , , - Nutrition & Metabolism 2019 被引用: 204

  6. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

    著者: , , , , , , , - Phytotherapy Research 2019 被引用: 86

  7. Hepatoprotective effect of quercetin: From chemistry to medicine

    著者: , , , , , , , , , - Food and Chemical Toxicology 2016 被引用: 213

  8. The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial

    著者: , , , , , - European Journal of Clinical Nutrition 2020 被引用: 71

  9. RETRACTED ARTICLE: The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial

    著者: , , , , , - European Journal of Nutrition 2019 被引用: 59

  10. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease

    著者: , , , , - Hepatitis Monthly 2015 被引用: 125

  11. Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies

    著者: , , , , , , , - Hepatitis Monthly 2014 被引用: 65

  12. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

    著者: , , , , - Nutrition 2013 被引用: 79

  13. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

    著者: , , , , - Hepatitis Monthly 2016 被引用: 104

  14. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

    著者: , , , , - Hepatitis Monthly 2016 被引用: 90

  15. Probiotic as a Novel Treatment Strategy Against Liver Disease

    著者: , , , , - Hepatitis Monthly 2013 被引用: 86

  16. Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trial.

    著者: , , - 2019 被引用: 24

  17. The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review

    著者: , , , , - Expert Review of Clinical Immunology 2023 被引用: 21

  18. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

    著者: , , , , , , , - BMC Complementary and Alternative Medicine 2019 被引用: 54

  19. Opioid Drugs in Patients With Liver Disease: A Systematic Review

    著者: , , , , - Hepatitis Monthly 2016 被引用: 117

  20. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV− mothers: a meta-analysis

    著者: , , , - Archives of Gynecology and Obstetrics 2010 被引用: 84

  21. Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

    著者: , , , , - Hepatitis Monthly 2013 被引用: 75

  22. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 被引用: 56

  23. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis

    著者: , , , , , , - Archives of Virology 2020 被引用: 40

  24. The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017

    著者: , - Clinical Liver Disease 2019 被引用: 30